Dialog Box

Skin Health Institute

Clinical Trials Now Recruiting

These study descriptions are intended for potential study participants. Study descriptions for clinicians can be found here.  

If you would like to learn more about any of the studies currently being conducted at the Skin Health Institute, please contact the nominated study coordinator.

If you have any general questions regarding the clinical trials conducted at the Institute, please feel free to contact the Clinical Trials Department at trials@skinhealthinstitute.org.au or by phone on (03) 9623 9439. 

HEALTHY VOLUNTEER BLOOD DONATION RESEARCH STUDY

Healthy volunteers aged 18 years or older, may qualify to donate up to 40mls of blood (equivalent to 3 tablespoons). The purpose of this research is to establish new bioassays (tests) that will support research and development of novel (new) biological therapies designed to target cancer, inflammatory, cardiovascular and Bleeding disorders (e.g. haemophilia).

To be eligible, participants must be 18 years or older and believe themselves to be HIV and Hepatitis B & C negative. Qualified participants may be asked to donate blood at regular intervals. Visits will take place at Skin Health Institute with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Approved by the Victorian Minister for Health under section 40 of the Human Tissue Act 1982.

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Desire Green
t: 9623 9439
e: dgreen@skinhealthinstitute.org.au

PLaque psoriasis research trial (32 weeks)

Adults aged 18 years or older with a diagnosis of plaque psoriasis for at least 6 months, may qualify to receive one of two investigational medications (active study drug) via subcutaneous injection. 

To be eligible, participants must have inadequately controlled moderate to severe plaque psoriasis currently treated with ustekinumab. Eligible participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses. 

Individuals will be asked to visit the study centre about 17 times over a period of about 32 weeks. 

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Jennifer Kaiser
t: 9623 9416
e: jkaiser@skinhealthinstitute.org.au

Psoriasis Research study (64 weeks)

Adults aged 18 years or older previously diagnosed with moderate to severe chronic plaque psoriasis, may qualify to receive investigational risankizumab treatment via subcutaneous injection.

To be eligible, participants must be on labeled secukinumab or ixekizumab treatment (for at least 6 months) and are experiencing a sub-optimal response, at the time of screening. Psoriasis involving 3% to less than 10% body surface area (BSA) is also required. Eligible participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 8 times over a period of about 64 weeks.

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Jennifer Kaiser
t: 9623 9416
e: jkaiser@skinhealthinstitute.org.au

Research study for Atopic Dermatitis (27 Weeks)

Males and females aged 18-75 with a documented history of chronic eczema/atopic dermatitis (AD) for at least 1 year, may qualify to receive investigational medication (active study drug) or placebo, via injection. Atopic Dermatitis is a chronic inflammatory skin disease commonly referred to as eczema.

To be eligible, participants must have a body mass index between 19 and 40 kg/m2 inclusive. Individuals must have moderate to severe disease severity, with AD that affects ≥ 10% of the body surface area. A documented history (within the past 6 months) of inadequate response to topical medications (corticosteroids) for AD, intolerance to treatment with topical medications for AD, or for whom topical medications are otherwise medically inadvisable, is also required. Eligible participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 12 times over a period of about 27 weeks.

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Charlotte Harrison-Mullan
t: 9623 9470
e: charrison@skinhealthinstitute.org.au

RESEARCH STUDY FOR NAIL FUNGUS (Topical)

Adults aged between 18 and 65 years with onychomycosis (nail fungus), may qualify to receive investigational medication (active study drug) or placebo, via a topical solution that will be brushed on to the infected toe. 

To be eligible, participants must have a fungal toenail infection on at least one big toe, and also be in good health based on past medical history and physical examination as determined by the research doctor at the screening visit. Eligible participants will have regular visits (onsite and phone calls) with an experienced research team.  There is no cost to participate, and participants will be reimbursed for study-related expenses.

Length of study participation will be up to 40 weeks.

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Sarah Chivers
t: 9623 9465
e: schivers@skinhealthinstitute.org.au

HIDRADENITIS SUPPURATIVA RESEARCH TRIAL (71 WEEKS)

Adults aged 18 years or older with a diagnosis of hidradenitis suppurativa (HS) for at least 6 months, may qualify to receive investigational medication (active study drug) or placebo, via injection.                           

To be eligible, participants must have HS lesions present in at least 2 distinct areas of the body. Moderate to severe disease with at least 5 inflammatory nodules or abscesses, must be present. Inadequate response to a course of a systemic antibiotic for the treatment of HS, is also required. Eligible participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 28 times over a period of about 71 weeks. 

For more information, please contact:

Principal Investigator
A/Prof Peter Foley

Sub Investigator
Dr. Nick Manuelpillai
t: 9623 9464
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator
Irina Danilovich
t: 9623 9448
e: idanilovich@skinhealthinstitute.org.au

RESEARCH STUDY FOR HIDRADENITIS SUPPURATIVA (26 weeks)

Adults aged 18-75 years old with a diagnosis of moderate to severe hidradenitis suppurativa (HS) for at least one year, may qualify to receive investigational oral medication (active study drug) or placebo. Participants must agree to use topical antiseptics daily, during study participation.

To be eligible, participants must have HS lesions present in at least 2 distinct areas of the body, with at least 4 inflammatory nodules or abscesses present. Inadequate response to at least a 4-week (28 day) trial of an oral antibiotic for the treatment of HS, is also required. Eligible participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 10 times over a period of about 26 weeks.

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr. Nick Manuelpillai
t: 9623 9400
e: nmanuelpillai@skinhealthinstitute.org.au

Study Coordinator:
Irina Danilovich
t: 9623 9448
e: idanilovich@skinhealthinstitute.org.au


How do I become involved in a clinical trial at the institute?

Anyone can participate in a clinical trial. A referral from a doctor is not necessary.

Contact the Clinical Trials Department directly to inquire about current research projects to determine your suitability
Phone: (03) 9623 9439
Email: trials@skinhealthinstitute.org.au

Donate